Baidu
map
EUR J HOSP PHARM 润色咨询

European Journal of Hospital Pharmacy

出版年份:暂无数据 年文章数:677 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:24.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1104876, encodeId=66ef11048e652, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104875, encodeId=7eac11048e5b8, content=IF是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542479, encodeId=a1215424e9f1, content=每当看到上涨时,心情就开心很多,虽然涨得不多,但是基数也不高呀,相对而言,还是令人欣慰的.明年努力,争取过1.5大关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ling_feng, createdTime=Fri Jul 14 18:49:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834962, encodeId=4d6c8349623a, content=涵盖了医院药学各个方面,包括科学、临床、治疗、经济和社会学,旨在促进医药和生物医学领域的创新和发展,为医院药剂师提供安全、有效和高性价比的药剂治疗实践建议。<br> 出版速度:投稿至初步决定:平均50天 <br> 接收至发表:平均15天(线上发表) 平均140天(纸刊发表) , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Dec 14 17:32:07 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2021-12-29 乌云背后的幸福线

    选刊时需结合IF进行吗?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1104876, encodeId=66ef11048e652, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104875, encodeId=7eac11048e5b8, content=IF是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542479, encodeId=a1215424e9f1, content=每当看到上涨时,心情就开心很多,虽然涨得不多,但是基数也不高呀,相对而言,还是令人欣慰的.明年努力,争取过1.5大关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ling_feng, createdTime=Fri Jul 14 18:49:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834962, encodeId=4d6c8349623a, content=涵盖了医院药学各个方面,包括科学、临床、治疗、经济和社会学,旨在促进医药和生物医学领域的创新和发展,为医院药剂师提供安全、有效和高性价比的药剂治疗实践建议。<br> 出版速度:投稿至初步决定:平均50天 <br> 接收至发表:平均15天(线上发表) 平均140天(纸刊发表) , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Dec 14 17:32:07 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2021-12-27 rayms

    IF是什么?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1104876, encodeId=66ef11048e652, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104875, encodeId=7eac11048e5b8, content=IF是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542479, encodeId=a1215424e9f1, content=每当看到上涨时,心情就开心很多,虽然涨得不多,但是基数也不高呀,相对而言,还是令人欣慰的.明年努力,争取过1.5大关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ling_feng, createdTime=Fri Jul 14 18:49:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834962, encodeId=4d6c8349623a, content=涵盖了医院药学各个方面,包括科学、临床、治疗、经济和社会学,旨在促进医药和生物医学领域的创新和发展,为医院药剂师提供安全、有效和高性价比的药剂治疗实践建议。<br> 出版速度:投稿至初步决定:平均50天 <br> 接收至发表:平均15天(线上发表) 平均140天(纸刊发表) , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Dec 14 17:32:07 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2017-07-14 ling_feng

    每当看到上涨时,心情就开心很多,虽然涨得不多,但是基数也不高呀,相对而言,还是令人欣慰的.明年努力,争取过1.5大关

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1104876, encodeId=66ef11048e652, content=选刊时需结合IF进行吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104875, encodeId=7eac11048e5b8, content=IF是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542479, encodeId=a1215424e9f1, content=每当看到上涨时,心情就开心很多,虽然涨得不多,但是基数也不高呀,相对而言,还是令人欣慰的.明年努力,争取过1.5大关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ling_feng, createdTime=Fri Jul 14 18:49:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834962, encodeId=4d6c8349623a, content=涵盖了医院药学各个方面,包括科学、临床、治疗、经济和社会学,旨在促进医药和生物医学领域的创新和发展,为医院药剂师提供安全、有效和高性价比的药剂治疗实践建议。<br> 出版速度:投稿至初步决定:平均50天 <br> 接收至发表:平均15天(线上发表) 平均140天(纸刊发表) , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Dec 14 17:32:07 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2016-12-14 ms9016875260525266

    涵盖了医院药学各个方面,包括科学、临床、治疗、经济和社会学,旨在促进医药和生物医学领域的创新和发展,为医院药剂师提供安全、有效和高性价比的药剂治疗实践建议。
    出版速度:投稿至初步决定:平均50天
    接收至发表:平均15天(线上发表) 平均140天(纸刊发表)

    0

共4条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map